Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
As a hold in an article today. Divis dropped into accounts today so there should be a reinvestment surge, Of course might fall back again after that but I feel about 500p is right for now and any good news could propel TSTL to 600p.
It looks like Tristel have taken advantage of Byotrols financial woes to purchase the IP to one of their formulations they were licencing from them.
'We then agreed to sell to Tristel the underlying IP relating to one of the three previously licensed formulations, the proceeds of which are included in the 'cash-generated' figure above. These two transactions are positive in cash terms but will also result in an exceptional accounting charge to our P&L at year end of £550k, reflecting a write-off of future minimum guaranteed royalties'
Thanks Iron! Liberum are a bit negative on TSTL still rating it a hold but have increased their TP to 420p citing the US ramp up will take longer than planned they think. However they haven't a good record on forecasting TSTl. I think we are starting to see small traction again and hopefully the ex divi fall will be absorbed. I find it always rises into the divi payment date where investors like myself reinvest the divi. The SP can be volatile here of course and there may be more directors sales so best to buy on dips imo.
Fallingk, Totally agree and your comments in the past have proved so accurate. The sp still seems to undervalue this thriving company.
Even the rise today is undervaluing the update. Interim Divi doubled and hopefully the final divi will rise in tandem. That will give me a nice safe yield. Hopefully more buyers will flood in when they see the potential.
Totally agree, excellent results, this should be £6 plus - still below 2021 levels !
Superb results today with an ancillary release of good news on EU approval of the new cache products for an untapped market. Doubling the divi is eye catching which would drive up the yield ordinarily but I expect a jump in the SP today in response. There could be sell on the news people but I didn't detect much positioning in the run up to results. Surely should be 500p and I think value must be 600p now as a growth stock.
And I expect buyers yo flood in pre results which I expect to have continued momentum. Probably a 10% gain to be had in two weeks from here.
Ah thanks one desk! Not quite hit it yet though but sentiment is with it. The Canadian deal has been the spur and dare I say it but we might even smash through 500p. 500p itself is almost a 20% gain since the director sells so not to be sniffed at and bound to see some profit taking.
Falling knife - a pretty good forecast of price and date it will be reached! Well done
Thanks Iron. A recovery already seems underway, so it was just a bump in the road. I can see 500p by Feb 22 or whenever the next update is
Fallingk, Value your opinion and hope you are correct. I could not see any reason for selling.
Not so Iron. The chairman is retiring shortly and both are perennial sellers anyway. I think the results will be good in the next trading update. Just a minor blip today.
Well CEO and CFO selling shares.. A vote of no confidence in the company . Given the very low sp for them to sell at this valuation suggests there are problems ahead.
But I expect a bounce to catch divi reinvesting peeps in two weeks. More bang for my buck.
This was 700p at one stage and we know they are flying from the last update. Rating is high but as long as the growth is there investors will pay it. I keep reinvesting the divis and as my largest holding it has served me well.
The spread up to 4.45% today share shows up 2.2% ...450p bid 460 ask.
This share went ex div 23/11/23 so I will get the last payment ( paid 22/12/23 )
The yield shown on this site above 1.5% is less then the 2.3% shown on other sites .
I see it is the back end of 2021 that I maxed out the margin , this purchased on borrowed money.
Rising interest rates this year have made a difference to wisdom of that idea.
But even at 6% cost this one worked out.
Not sure if it pays a div .
Sold them for a target set 440p which failed yesterday. got *445p today ( spread 2.5% )
Only 35 messages on this BB . since my buy 21/2/2022,.
350 to 445 = 27% over 1 year 9 months.
Good luck to those buying into rise hope this keeps rising for you all .
Just spotted this report on MSN:
https://phys.org/news/2023-11-chlorine-disinfectant-effective-hospital-superbug.html
"One of the primary chlorine disinfectants currently being used to clean hospital scrubs and surfaces does not kill off the most common cause of antibiotic-associated sickness in health care settings globally, according to a new study.
Research by the University of Plymouth has shown that spores of Clostridioides difficile, commonly known as C. diff, are completely unaffected despite being treated with high concentrations of bleach used in many hospitals.
In fact, the chlorine chemicals are no more effective at damaging the spores when used as a surface disinfectant—than using water with no additives.
Writing in the journal Microbiology, the study's authors say susceptible people working and being treated in clinical settings might be unknowingly placed at risk of contracting the superbug.
As a result, and with incidence of biocide overuse only serving to fuel rises in antimicrobial resistance (AMR) worldwide, they have called for urgent research to find alternative strategies to disinfect C. diff spores in order to break the chain of transmission in clinical environments."
Perhaps they are not aware of Tristel’s Cache collection!
Adverse broker comment skittles this yesterday. Appears in its opinion unproven and rating is still high. Can't say I agree and we can see buyers back today without moving the needle admittedly.
At least the divi reinvested will buy more shares. Ridiculous fall and I wonder did some adverse media coverage trigger it?
The sp now back to pre results value..It seems the results were seen as merely satisfactory by the markets. Just wunder what would constitute something positive
Still cannot understand the slump in the sp. These results are impressive yet the market remains mildly satisfied.
ShareSoc is holding its first hybrid event in London on 19th Oct! Hear from Tristel Plc (TSTL) and other healthcare companies like Inspiration Healthcare Group (IHC), Creo Medical Group (CREO), Abingdon Health (ABDX) and GENincode (GENI). Attend in-person or online. 📍🌐 Register: https://bit.ly/3FbyXfe